Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-EN
Language French English
Date Updated 2018-08-21 2018-07-15
Drug Identification Number 02453452 02453452
Brand name APO-OLMESARTAN APO-OLMESARTAN
Common or Proper name OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL
Company Name APOTEX INC APOTEX INC
Ingredients OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-09-03 2018-09-03
Actual start date
Estimated end date Unknown
Actual end date 2018-08-17
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments